![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 11
2016
Krug, U.; Berdel, W. E.; Gale, R. P.; Haferlach, C.; Schnittger, S.; Müller-Tidow, C.; Braess, J.; Spiekermann, K.; Staib, P.; Beelen, D.; Serve, H.; Schliemann, C.; Stelljes, M.; Balleisen, L.; Maschmeyer, G.; Grüneisen, A.; Eimermacher, H.; Giagounidis, A.; Rasche, H.; Hehlmann, R.; Lengfelder, E.; Thiel, E.; Reichle, A.; Aul, C.; Ludwig, W.-D.; Kern, W.; Haferlach, T.; Köpcke, W.; Görlich, D.; Sauerland, M. C.; Heinecke, A.; Wörmann, B. J.; Hiddemann, W. und Büchner, T.
(2016):
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
In: Leukemia, Bd. 30, Nr. 6: S. 1230-1236
Bellos, F.; Sotlar, K.; Jeromin, S.; Haferlach, C.; Haferlach, T. und Kern, W.
(2016):
Assessment of CD30 expression on mast cells in systemic mastocytosis by immunohistochemistry versus multiparameter flow cytometry and correlation to clinical parameters.
In: Oncology Research and Treatment, Bd. 39: S. 152
2009
Schmidt, Heinrich; Giese, Renate; Enders, Angelika; Kern, W. und Hallschmid, M.
(2009):
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.
In: Journal of Medical Genetics, Bd. 46: S. 217-222
[PDF, 584kB]
2005
Schoch, C.; Kohlmann, A.; Dugas, Martin; Kern, W.; Hiddemann, Wolfgang; Schnittger, S. und Haferlach, T.
(2005):
Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.
In: Leukemia, Bd. 19, Nr. 7: S. 1224-1228
Kohlmann, A.; Schoch, C.; Dugas, Martin; Rauhut, S.; Weninger, F.; Schnittger, S.; Kern, W. und Haferlach, T.
(2005):
Pattern robustness of diagnostic gene expression signatures in leukemia.
In: Genes, Chromosomes and Cancer, Bd. 42, Nr. 3: S. 299-307
Kohlmann, A.; Schoch, C.; Dugas, Martin; Schnittger, S.; Hiddemann, Wolfgang; Kern, W. und Haferlach, T.
(2005):
New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.
In: Leukemia, Bd. 19, Nr. 6: S. 953-964
Haferlach, T.; Kohlmann, A.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Schoch, C.
(2005):
AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.
In: Genes, Chromosomes and Cancer, Bd. 43, Nr. 2: S. 113-127
Haferlach, T.; Kohlmann, A.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Schoch, C.
(2005):
Global approach to the diagnosis of leukemia using gene expression profiling.
In: Blood, Bd. 106, Nr. 4: S. 1189-1198
2004
Kohlmann, A.; Schoch, C.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Haferlach, T.
(2004):
Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients.
In: Leukemia, Bd. 18, Nr. 1: S. 63-71
2003
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, Martin; Hiddemann, Wolfgang und Haferlach, T.
(2003):
Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia.
In: Haematologica, Bd. 88, Nr. 3: S. 351-352
Kohlmann, A.; Schoch, C.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Haferlach, T.
(2003):
Molecular characterization of acute leukemias by use of microarray technology.
In: Genes, Chromosomes and Cancer, Bd. 37, Nr. 4: S. 396-405